Phase I/II Trial of VELCADE Plus Zevalin in Patients With Relapsed or Refractory Follicular Lymphoma
Condition(s):LymphomaLast Updated:September 4, 2019Terminated
Hide Studies Not Open or Pending
Condition(s):LymphomaLast Updated:September 4, 2019Terminated
Condition(s):Mantle Cell LymphomaLast Updated:September 21, 2023Completed
Condition(s):Follicular LymphomaLast Updated:September 28, 2023Terminated
Condition(s):LymphomaLast Updated:November 5, 2014Completed
Condition(s):LymphomaLast Updated:July 21, 2014Terminated
Condition(s):Hodgkin Lymphoma; Non Hodgkin LymphomaLast Updated:January 25, 2024Terminated
Condition(s):LymphomaLast Updated:November 18, 2023Active, not recruiting
Condition(s):Lymphoma; Lymphoma, Large B-Cell, DiffuseLast Updated:February 23, 2024Recruiting
Condition(s):LymphomaLast Updated:May 20, 2013Completed
Condition(s):Mantle Cell Lymphoma; LymphomaLast Updated:January 25, 2024Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.